G2 Investment Partners Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-55,000
Closed -$1.4M 74
2025
Q2
$1.4M Buy
+55,000
New +$1.2M 0.31% 54
2016
Q1
Sell
-14,308
Closed -$431K 84
2015
Q4
$431K Sell
14,308
-17,862
-56% -$573K 0.13% 68
2015
Q3
$1.02M Sell
32,170
-18,064
-36% -$660K 0.38% 42
2015
Q2
$1.96M Sell
50,234
-6,050
-11% -$209K 0.72% 36
2015
Q1
$1.99M Sell
56,284
-18,620
-25% -$599K 0.77% 40
2014
Q4
$2.36M Buy
74,904
+29,953
+67% +$828K 0.75% 41
2014
Q3
$1.01M Buy
44,951
+19,629
+78% +$393K 0.34% 62
2014
Q2
$556K Buy
+25,322
New +$481K 0.2% 72

Other funds holding PAHC

G2 Investment Partners Management's PAHC Position: Q3 2025 in Review

G2 Investment Partners Management sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 55,000 shares — an estimated $1.4M sold.

G2 Investment Partners Management first reported a position in PAHC in Q2 2014 and held it in 8 quarters. The position peaked at $2.36M in Q4 2014. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • G2 Investment Partners Management reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • G2 Investment Partners Management sold 55,000 Phibro Animal Health shares in Q3 2025, an estimated $1.4M.
  • G2 Investment Partners Management first reported a position in Phibro Animal Health in Q2 2014 and held it in 8 quarters.
  • G2 Investment Partners Management's Phibro Animal Health position peaked at $2.36M in Q4 2014.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on G2 Investment Partners Management's 13F filing for Q3 2025, filed 14 Nov 2025.